共 50 条
- [2] PD-L1 expression and tumor mutational burden status for prediction of response to chemotherapy and targeted therapy in non-small cell lung cancer [J]. Journal of Experimental & Clinical Cancer Research, 38
- [5] Integration of comprehensive genomic profiling, tumor mutational burden, and PD-L1 expression to identify novel biomarkers of immunotherapy in non-small cell lung cancer [J]. CANCER MEDICINE, 2021, 10 (07): : 2216 - 2231
- [10] Tumor Mutational Burden and PD-L1 Expression in Non-Small-Cell Lung Cancer (NSCLC) in Southwestern China [J]. ONCOTARGETS AND THERAPY, 2020, 13 : 5191 - 5198